These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 309446)

  • 21. Comparative distribution of misonidazole and its amine metabolite in female Swiss Webster mice.
    Born JL; Hadley WM
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1157-61. PubMed ID: 3997598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of misonidazole on the radiosensitivity and repair of potentially lethal damage of L5178Y ascites tumor cells.
    Nakagawa K; Tsunemoto H; Watanabe I
    Eur J Cancer Clin Oncol; 1983 Apr; 19(4):527-32. PubMed ID: 6683187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M; Fukuda H; Nakajima T; Sugimoto K; Onoyama Y; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular and chemical reduction products of misonidazole.
    Varghese AJ; Whitmore GF
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ; Whitmore GF
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
    Astor M; Hall EJ; Biaglow JE; Parham JC
    Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
    Shoemaker D; Upton D; Strong J
    Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione conjugates of misonidazole.
    Varghese AJ
    Biochem Biophys Res Commun; 1983 May; 112(3):1013-20. PubMed ID: 6847675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reaction of 2-nitroimidazole metabolites with guanine and possible biological consequences.
    Whitmore GF; Varghese AJ; Gulyas S
    IARC Sci Publ; 1986; (70):185-96. PubMed ID: 3793172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No significant effect of cimetidine on the pharmacokinetics of misonidazole in man.
    Begg EJ; Williams KM; Wade DN; O'Shea KF
    Br J Clin Pharmacol; 1983 May; 15(5):575-6. PubMed ID: 6860535
    [No Abstract]   [Full Text] [Related]  

  • 34. The neurotoxicity of radiosensitizing drugs: a biochemical assessment of desmethylmisonidazole (DMM) in the rat.
    Rose GP; Taylor JM
    Toxicology; 1985 Jan; 34(1):43-56. PubMed ID: 3918357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP; Gulyas S; Whitmore GF
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro assessment of the oncogenic potential of nitroimidazole radiosensitizers.
    Hei TK; Geard CR; Osmak RS; Hall EJ
    Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1653-8. PubMed ID: 3839777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A drug for improved radiosensitization in radiotherapy.
    Dische S; Fowler JF; Saunders MI; Stratford MR; Anderson P; Minchinton AI; Lee ME
    Br J Cancer; 1980 Jul; 42(1):153-5. PubMed ID: 7426325
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of specific reductases in the intracellular activation and binding of 2-nitroimidazoles.
    Joseph P; Jaiswal AK; Stobbe CC; Chapman JD
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):351-5. PubMed ID: 8195032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-enhanced cytotoxicity of misonidazole.
    Korbelik M; Palcic B; Skarsgard LD
    Radiat Res; 1981 Nov; 88(2):343-53. PubMed ID: 7302140
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.